Ta Von, Weldon Brittany, Yu Grace, Humblet Olivier, Neale-May Susan, Nadeau Kari
2351 Clay Street, Suite 380, San Francisco, CA 94115, Department of Internal Medicine, California Pacific Medical Center, California, United States.
Br J Med Med Res. 2011;1(4):410-429. doi: 10.9734/bjmmr/2011/711.
To determine whether specific IgE and skin prick test correlate better in predicting reaction severity during a double-blinded placebo controlled food challenge (DBPCFC) for egg, milk, and multiple tree nut allergens. STUDY DESIGN: Prospective study. PLACE AND DURATION OF STUDY: Department of Pediatrics, Stanford University School of Medicine, August 2009 and ongoing. METHODOLOGY: We examined the reaction severity of twenty-four subjects to nine possible food allergens: milk, egg, almond, cashew, hazelnut, peanut, sesame, pecan and walnut. Specific IgE and SPT were performed before each DBPCFC. DBPCFC results were classified into mild (1), moderate (2), or severe (3) reactions using a modified Bock's criteria. RESULTS: Twenty four subjects underwent a total of 80 DBPCFC. Eighty percent of all DBPCFCs resulted in a positive reaction. A majority, 71%, were classified as mild. No reactions occurred with a SPT of zero mm while three reactions occurred with a negative specific IgE. All reactions were reversible with medication. CONCLUSION: These data suggest that SPT and specific IgE levels are not associated with reaction severity (p<0.64 and 0.27, respectively). We also found that combining specific IgE and SPT improved specificity but did not help to achieve clinically useful sensitivity. For instance, an SPT > 5mm had a sensitivity of 91% and specificity of 50%. Combining SPT > 5mm and IgE > 7 resulted in a reduced sensitivity of 64%. Unexpectedly, a history of anaphylaxis 70% (n=17) was not predictive of anaphylaxis on challenge 4% (n=2).
确定在针对鸡蛋、牛奶和多种坚果过敏原的双盲安慰剂对照食物激发试验(DBPCFC)中,特异性IgE和皮肤点刺试验在预测反应严重程度方面是否具有更好的相关性。
前瞻性研究。
斯坦福大学医学院儿科学系,2009年8月至今。
我们检查了24名受试者对9种可能的食物过敏原的反应严重程度:牛奶、鸡蛋、杏仁、腰果、榛子、花生、芝麻、山核桃和核桃。在每次DBPCFC之前进行特异性IgE和皮肤点刺试验。使用改良的博克标准将DBPCFC结果分为轻度(1级)、中度(2级)或重度(3级)反应。
24名受试者共进行了80次DBPCFC。所有DBPCFC中有80%产生了阳性反应。大多数(71%)被归类为轻度。皮肤点刺试验为0毫米时未发生反应,而特异性IgE为阴性时发生了3次反应。所有反应均可通过药物逆转。
这些数据表明,皮肤点刺试验和特异性IgE水平与反应严重程度无关(p分别<0.64和0.27)。我们还发现,将特异性IgE和皮肤点刺试验相结合可提高特异性,但无助于实现临床有用的敏感性。例如,皮肤点刺试验>5毫米时敏感性为91%,特异性为50%。将皮肤点刺试验>5毫米和IgE>7相结合导致敏感性降低至64%。出乎意料的是,70%(n = 17)有过敏反应史的患者在激发试验时未发生过敏反应,4%(n = 2)发生了过敏反应。